There was a trend toward higher miRNA-148a expression in mucinous adenocarcinoma compared to adenocarcinoma (p = 0.068), but there were no associations with other major clinical and pathological features (such as age, gender, tumor location and size, lymph node involvement, number or site of metastases, KRAS mutation status). This evidence concerns the gene KRAS and neoplasm.